Feedback / Questions
Memogain (galantamine prodrug) - Alpha Cognition
https://www.businesswire.com/news/home/20240222276486/en/Alpha-Cognition-Files-U.S.-Patent-Application-Covering-an-ALPHA-1062-Oral-Formulation-to-Treat-Mild-to-Moderate-Alzheimer%E2%80%99s-Disease
Feb 22, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next